Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Life (Basel, Switzerland)|November 11, 2022
Molecular Mechanisms of Action of Eugenol in Cancer: Recent Trends and AdvancementIpsa Padhy, Paramita Paul, Tripti Sharma, et al.
Indian Journal of Dermatology|April 5, 2014
Disseminated Cutaneous Histoplasmosis, an Initial Manifestation of HIV, Diagnosed with Fine Needle Aspiration CytologySankha Koley, Rajesh Kumar Mandal, Kalyan Khan, et al.
Natural Product Research|January 21, 2025
Exploring the anti-diabetic potential of <i>Aloe vera</i>: isolation and characterization of bioactive compoundsIvy Ghosh, Sabyasachi Banerjee, Subhasish Dutta, et al.
Colloids and Surfaces. B, Biointerfaces|July 5, 2021
Myco-nanotechnological approach to synthesize silver oxide nanocuboids using endophytic fungus isolated from Citrus pseudolimon plantAman Kumar, Suresh Kumar, Kumari Kiran, et al.
Pharmaceutics|August 26, 2023
Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent UpdateArijit Mondal, Amit Kumar Nayak, Prithviraj Chakraborty, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 15, 2008
Chromatographic purification of equine immunoglobulin G F(ab)2 from plasmaAldon Fernandes, John Oswald Kaundinya, Gautam Daftary, et al.
Cancers|May 27, 2026
Potential of Dietary Agent Daidzein in Cancer Prevention and Treatment: Opportunities and ChallengesSubhadas Chatterjee, Sabyasachi Banerjee, Sankhadip Bose, et al.
Reproductive Biology and Endocrinology : RB&E|December 27, 2011
Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantationAnne E Chambers, Krishnaveni P Nayini, Walter E Mills, et al.
Current Pharmaceutical Design|April 10, 2025
Metformin and its Nanoformulations in Cancer Prevention and TherapyBiswajit Banerjee, Sabyasachi Banerjee, Tripti Sharma, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2004
Placental expression of interferon-gamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsiaSubhasis Banerjee, Alan Smallwood, Jane Moorhead, et al.
Pageof 7